Glucose dysregulation and repolarization variability markers are short-term mortality predictors in decompensated heart failure. Issue 3 (30th May 2022)
- Record Type:
- Journal Article
- Title:
- Glucose dysregulation and repolarization variability markers are short-term mortality predictors in decompensated heart failure. Issue 3 (30th May 2022)
- Main Title:
- Glucose dysregulation and repolarization variability markers are short-term mortality predictors in decompensated heart failure
- Authors:
- Piccirillo, Gianfranco
Moscucci, Federica
Carnovale, Myriam
Corrao, Andrea
Di Diego, Ilaria
Lospinuso, Ilaria
Sciomer, Susanna
Rossi, Pietro
Magrì, Damiano - Abstract:
- Abstract : Objective: As recently reported, elevated fasting glucose plasma level constitutes a risk factor for 30-day total mortality in acutely decompensated chronic heart failure (CHF). Aim of this study was to evaluate the 30-day mortality risk in decompensated CHF patients by fasting glucose plasma level and some repolarization ECG markers. Method: A total of 164 decompensated CHF patients (M/F: 94/71; mean age, 83 ± 10 years) were studied; Tend (Te), QT interval (QT) and 5 min of ECG recordings were obtained, studying mean, SD and normalized index of the abovementioned ECG intervals. These repolarization variables and fasting glucose were analyzed to assess the 30-day mortality risk among these patients. Results: Thirty-day mortality rate was 21%, deceased subjects showed a significant increase in N terminal-pro-brain natriuretic peptide ( P < 0.001), higher sensitivity cardiac troponin, fasting glucose, creatinine clearance, QTSD, QTVN, Te mean, TeSD and TeVN than the survivals. Multivariable regression analysis reported that fasting glucose (hazard ratio, 1.59; 95% confidence interval, 1.09–2.10; P < 0.01), Te mean (hazard ratio, 1.03; 95% confidence interval, 1.01–1.05; P < 0.01) and QTSD (hazard ratio, 1.17; 95% confidence interval, 1.01–1.36; P < 0.05) were significantly related to higher mortality risk, whereas only fasting glucose (hazard ratio, 1.84; 95% confidence interval, 1.12–3.02; P < 0.05) and Te mean (hazard ratio, 1.07; 95% confidence interval,Abstract : Objective: As recently reported, elevated fasting glucose plasma level constitutes a risk factor for 30-day total mortality in acutely decompensated chronic heart failure (CHF). Aim of this study was to evaluate the 30-day mortality risk in decompensated CHF patients by fasting glucose plasma level and some repolarization ECG markers. Method: A total of 164 decompensated CHF patients (M/F: 94/71; mean age, 83 ± 10 years) were studied; Tend (Te), QT interval (QT) and 5 min of ECG recordings were obtained, studying mean, SD and normalized index of the abovementioned ECG intervals. These repolarization variables and fasting glucose were analyzed to assess the 30-day mortality risk among these patients. Results: Thirty-day mortality rate was 21%, deceased subjects showed a significant increase in N terminal-pro-brain natriuretic peptide ( P < 0.001), higher sensitivity cardiac troponin, fasting glucose, creatinine clearance, QTSD, QTVN, Te mean, TeSD and TeVN than the survivals. Multivariable regression analysis reported that fasting glucose (hazard ratio, 1.59; 95% confidence interval, 1.09–2.10; P < 0.01), Te mean (hazard ratio, 1.03; 95% confidence interval, 1.01–1.05; P < 0.01) and QTSD (hazard ratio, 1.17; 95% confidence interval, 1.01–1.36; P < 0.05) were significantly related to higher mortality risk, whereas only fasting glucose (hazard ratio, 1.84; 95% confidence interval, 1.12–3.02; P < 0.05) and Te mean (hazard ratio, 1.07; 95% confidence interval, 1.02–1.11; P < 0.01) were associated to cardiovascular mortality. Conclusion: Data suggest that two simple, inexpensive, noninvasive markers, as fasting glucose and Te, were capable to stratify the short-term total and cardiovascular mortality risk in acutely decompensated CHF. … (more)
- Is Part Of:
- Cardiovascular endocrinology & metabolism. Volume 11:Issue 3(2022)
- Journal:
- Cardiovascular endocrinology & metabolism
- Issue:
- Volume 11:Issue 3(2022)
- Issue Display:
- Volume 11, Issue 3 (2022)
- Year:
- 2022
- Volume:
- 11
- Issue:
- 3
- Issue Sort Value:
- 2022-0011-0003-0000
- Page Start:
- Page End:
- Publication Date:
- 2022-05-30
- Subjects:
- acutely decompensated heart failure -- diabetes -- ECG markers -- Tpeak–Tend
Cardiovascular system -- Diseases -- Periodicals
Endocrine glands -- Diseases -- Periodicals
Endocrinology -- Periodicals
Metabolism -- Disorders -- Periodicals
Diabetes -- Periodicals
616.1 - Journal URLs:
- https://journals.lww.com/cardiovascularendocrinology/pages/default.aspx ↗
http://journals.lww.com/pages/default.aspx ↗ - DOI:
- 10.1097/XCE.0000000000000264 ↗
- Languages:
- English
- ISSNs:
- 2574-0954
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3051.462650
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 21736.xml